Hester Biosciences Limited has responded to emails from NSE and BSE dated 25 April 2025, seeking clarification regarding the recent movement in the price of the Company’s securities.

The company clarified that there is no pending information, announcement, or event which, in their opinion, may have a bearing on the price or volume behavior of the Company's securities.

They stated there is no information requiring disclosure under Regulation 30 or any other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Hester Biosciences believes the movement in securities price and volume is purely due to market conditions and entirely market driven, and the Company is neither connected to nor has any knowledge of any specific reason for the movement.